Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fp Nutraceuticals LLC currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This application is being reviewed by GREENE, IVAN A, who is the busiest examiner for the portfolio with 1 pending office action. The prosecution effort is concentrated under 1 distinct examiner and 1 distinct art unit, suggesting a very targeted technical focus for the company's pending matter.
Because there is only 1 pending office action, Fp Nutraceuticals LLC has a single point of contact at the patent office. This alignment with GREENE, IVAN A allows the applicant to focus on the specific procedural and technical requirements of 1 distinct examiner. However, the lack of diversity across 1 distinct art unit means that the company's current efforts in the Biotechnology & Pharmaceuticals sector are subject to the specific interpretive standards of a single group, making the relationship with this examiner critical for success.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GREENE, IVAN A | 1 | 18.8% | +6.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18969591 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS | GREENE, IVAN A | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18969591 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS | GREENE, IVAN A | 1619 | §102§103§112Other | Non-Final OA | — | Pending | Dec 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFp Nutraceuticals LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ivan A Greene has the most, with 1 of Fp Nutraceuticals LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
